Ricardo Gehrau.

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Oxaliplatin-based regimens are standard treatments for the patients with colorectal cancer (CRC) and advanced gastric cancer (AGC). However, owing to hepatic sinusoidal obstruction syndrome (SOS), the use of oxaliplatin sometimes results in splenomegaly. The aim of the present study was to evaluate the correlation between chemotherapy-associated changes of(More)
  • 1